Home/Products/Cardiology/TELPATH-AM
Telmisartan & Amlodipine Tablets IP
A fixed-dose combination of an angiotensin II receptor blocker with a dihydropyridine calcium channel blocker, used in the management of hypertension where combination therapy is appropriate.
| Composition | Telmisartan IP 40 mg Amlodipine Besylate IP eq. to Amlodipine 5 mg |
|---|---|
| Dosage form | Uncoated bilayered tablet |
| Pack size | 10 × 10 |
| Schedule | Prescription only (Rx) |
| Therapy area | Cardiology |
| Storage | Store in a cool, dry & dark place. Keep out of reach of children. |
Pregnancy warning. When pregnancy is detected, telmisartan should be discontinued as soon as possible. Drugs acting directly on the renin-angiotensin system can cause injury and even death to the developing foetus when used during the second and third trimesters of pregnancy.
Full prescribing information. This page is a summary for the reference of registered medical practitioners. Please refer to the pack insert for complete prescribing information including contraindications, warnings, precautions, drug interactions and adverse reactions.
To be sold by retail on the prescription of a Registered Medical Practitioner only.
